Rani Therapeutics Holdings (RANI) Assets (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Assets of $51.9 million for Q1 2026, up 115.04% year-over-year from $24.1 million in Q1 2025, and down 11.5% quarter-over-quarter from $58.6 million in Q4 2025.
Rani Therapeutics Holdings (RANI) Assets (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Assets history runs 7 years deep, the most recent figure standing at $51.9 million for Q1 2026.
- In Q1 2026, Assets rose 115.04% year-over-year to $51.9 million; the TTM figure through Mar 2026 stood at $51.9 million (up 115.04% YoY), while the FY2025 annual figure was $58.6 million, up 60.02% from the prior year.
- Assets for Q1 2026 stood at $51.9 million, down from $58.6 million in the prior quarter.
- The five-year high for Assets was $115.3 million in Q1 2022, with the low at $10.1 million in Q3 2025.
- The 5-year median for Assets is $57.9 million (2023), against an average of $63.7 million.
- The sharpest annual moves came in 2025 and 2026: Assets sank 76.71% in 2025, then soared 115.04% in 2026.
- Rani Therapeutics Holdings' Assets stood at $108.0 million in 2022, then tumbled by 46.39% to $57.9 million in 2023, then plunged by 36.75% to $36.6 million in 2024, then surged by 60.02% to $58.6 million in 2025, then decreased by 11.5% to $51.9 million in 2026.
- Business Quant data shows RANI's Assets at $51.9 million in Q1 2026, $58.6 million in Q4 2025, and $10.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | 60.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.84 Mn |
| Mar 31, 2026 | 51.88 Mn |
| Dec 31, 2025 | 58.62 Mn |
| Sep 30, 2025 | 10.14 Mn |
| Jun 30, 2025 | 16.90 Mn |
| Mar 31, 2025 | 24.13 Mn |
| Dec 31, 2024 | 36.63 Mn |
| Sep 30, 2024 | 43.54 Mn |
| Jun 30, 2024 | 43.73 Mn |
| Mar 31, 2024 | 53.51 Mn |
| Dec 31, 2023 | 57.92 Mn |
| Sep 30, 2023 | 70.44 Mn |
| Jun 30, 2023 | 83.51 Mn |
| Mar 31, 2023 | 96.45 Mn |
| Dec 31, 2022 | 108.03 Mn |
| Sep 30, 2022 | 108.20 Mn |
| Jun 30, 2022 | 104.34 Mn |
| Mar 31, 2022 | 115.31 Mn |
| Dec 31, 2021 | 124.21 Mn |
| Sep 30, 2021 | 136.96 Mn |